Calving rates in a tropical beef herd after treatment with a synthetic progestagen, norgestomet, or a prostaglandin analogue, cloprostenol.
Maiden heifers and lactating cows of known ovarian status and of several breeds were treated with a synthetic prostaglandin, cloprostenol, or a synthetic progestagen, norgestomet, at the start of an artificial insemination (AI) program. Animals in the cloprostenol treatment received 2 injections 10 days apart. Over the next 26 days those animals that showed oestrous behaviour were inseminated. Synchronisation rates and calving rates to insemination over the first 7 days were calculated. Those in the norgestomet treatment received an implant of norgestomet plus an injection of norgestomet and oestradiol valerate. The implant was removed 10 days later and the animals were given an injection of pregnant mare serum gonadotrophin (PMSG). They were inseminated at 48 h (maiden heifers) or 56 h (lactating cows) after implant removal. Calving rates to fixed-time insemination were recorded. After completion of the AI program the animals in both treatments were joined with bulls. Overall calving rates (AI plus bulls) were calculated. By day 7 of the program, 82% of the maiden heifers and 76% of the lactating cows in the cloprostenol treatment had been detected in oestrus. By day 21 the respective figures were 99% and 81%. Norgestomet treatment had an immediate and a prolonged effect on ovarian activity in those females classified as having inactive ovaries at the start of the AI program. Calving rates of those females to fixed-time AI and overall were similar to those of the females with active ovaries in both treatments. Their calving rates to fixed-time insemination, and overall calving rates for the lactating females, were significantly higher than the corresponding values of their contemporaries treated with cloprostenol and inseminated on observed oestrus over 7 days. For those females classified as having active ovaries at the start of the AI program, calving rates to first insemination and overall were similar for both treatments. Overall calving rates of lactating cows of each breed were, with one exception, higher in the norgestomet treatment than in the cloprostenol treatment. Although norgestomet treatment was more expensive than cloprostenol treatment, the advantage in calf crop resulted in an overall monetary advantage to the norgestomet treatment.
Frisch
J E
JE
CSIRO, Division of Tropical Animal Production, Rockhampton Mail Centre, Queensland.
O'Neill
C J
CJ
D000818:Animals; D002417:Cattle / Q000502:physiology*; D003008:Cloprostenol / Q000494:pharmacology*; D004973:Estrus Synchronization; D005260:Female; D005298:Fertility / Q000187:drug effects* / Q000502:physiology; D006064:Gonadotropins, Equine / Q000494:pharmacology; D007315:Insemination, Artificial / Q000662:veterinary; D007774:Lactation / Q000187:drug effects; D010053:Ovary / Q000187:drug effects / Q000502:physiology; D011247:Pregnancy; D018873:Pregnancy Rate; D011282:Pregnenediones / Q000494:pharmacology*; D011461:Prostaglandins F, Synthetic / Q000494:pharmacology*
D006064:Gonadotropins, Equine; D011282:Pregnenediones; D011461:Prostaglandins F, Synthetic; C100284:norgestomet; D003008:Cloprostenol